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Abstract
Objects Our objective was to develop an oligonucleotide
DNA microarray (OMA) for genome-wide microRNA
profiling and use this method to find miRNAs, which
control organic development especially for nervous system.
Materials and methods Eighteen organic samples included
cerebrum and spinal cord samples from two aborted human
fetuses. One was 12 gestational weeks old (G12w) and the
other was 24 gestational weeks old (G24w). Global miRNA
expression patterns of different organs were investigated
using OMA and Northern blot.
Conclusion The OMA revealed that 72–83% of miRNAs
were expressed in human fetal organs. A series of micro-
RNAs were found specifically and higher-expressed in the
human fetal nervous system and confirmed consistently by
Northern blot, which may play a critical role in nervous
system development.
Keywords MicroRNA.Oligonucleotidemicroarray.
Expressionprofile.Nervoussystemdevelopment
Introduction
To date, 326 microRNAs (miRNAs), a ubiquitous family of
about 22-nt noncoding regulatory RNAs, have been iden-
tified in the human genome and published in a database
(http://www.sanger.ac.uk/Software/Rfam/mirna/index.
shtml)[ 1]. Although more than 200 distinct miRNAs are
predicted in the human genome, little is known about their
biological functions, especially during embryonic develop-
ment. MiRNAs regulate target genes at the post-transcrip-
tional level and play important roles in development and
cell lineage decisions. However, in vertebrates, neither the
targets of miRNAs nor their expression profiles during
development are well understood. Some miRNAs are
specifically expressed in individual tissues and at particular
developmental stages. The developmental or tissue-specific
patterns of miRNA expression observed may suggest
analogous roles in regulating human development or
cellular differentiation [2–4].
A major obstacle in the study of miRNA function is the
lack of methods for quantitative expression profiling. The
miRNA microarray method, a powerful tool for global
analysis of miRNA expression first reported by Krichevsky
et al. [5], is based on a membrane array spotted with
specific antisense mature miRNA oligonucleotides. Since
then, other types of oligonucleotide array methods have
been published, including arrays on glass slides and on
beads [6–9].
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established and used to identify the expression of 158
miRNAs in human fetal organs. The oligonucleotide
microarray (OMA) was designed according to the method
of Liu [7], with modifications. We used miRNA micro-
arrays to study the profiles of miRNA expression in
nervous tissue samples and other organic samples from
two fetuses. Some clusters of miRNA families were co-
expressed, providing clues about the maturation processes
of miRNAs. At the same time, we found a high
concordance between our array results and those from
Northern blots. The microarray described here offers more
comprehensive coverage and higher throughput than other
methods, represents a powerful tool to better understand
miRNA expression profiles in human tissues, and provides
clues to the mechanisms for regulating protein translation.
Materials and methods
Samples and RNA extraction
Two fetal abortuses [12 weeks (G12w) and 24 weeks
(G24w) gestational age] tissues were obtained from the
National Infrastructure Program of the Chinese Genetic
Resources after obtaining informed consent. The G12w
tissues were liver, kidney, cerebrum, lung, and heart, and
the G24w tissues were the same, plus ovary, spleen,
hypothalamus, pancreas, and cervical, thoracic, lumbar,
and sacral spinal cord. Total RNA was isolated using
TRIZOL reagent (Invitrogen) according to the manufac-
turer’s standard protocol, and mRNA was purified by
oligotex (Qiagen).
Microarray design
The miRNA oligonucleotide microarray design was based
on that of spotted OMAs by Liu et al. [7], with significant
modifications. The mature miRNA sequences, which
ranged from 19 to 24 nt, were too short, so two probes
were designed for several miRNAs, one containing active
sites that detected both the mature and the precursor forms
(probe a), while the other did not contain the active sites
located in the precursor (probe b). An oligo probe was
designed that was not homologous to any human sequence
and was used as normalization control (control oligo); the
sequence was 5′ ATGTCATCTTGCGCGGCAGCTCGTC
GACCGTGGCGAGAGT GTCTCGTCGATCATC 3′. All
oligos were 40 nt long. In theory, the mature miRNA
expression level can be determined by subtracting the (a)
signal from the (b) signal. Nine probes for nine tRNA genes
were used as positive controls and six probes for six types
of miRNA genes from Arabidopsis thaliana were used as
negative controls.
Microarray fabrication
All probes were dissolved in 150 mM phosphate acid buffer
(pH 7.5–8.0) to a final concentration of 25 pmol/μl. Then
the control oligo was added to each miRNA probe at
2 pmol/μl. The OMAs were spotted by a GeneMachine
OmniGrid 100 Microarrayer in a 1×4 pin and 9×8 spot
configuration for each subarray with triplicates. The
spotting conditions were 75% humidity and 20°C. After
spotting, slides were hydrated overnight in saturated salt
solution and then crosslinked with UV light at 600 mJ/cm
2
(UVP CL1000).
Sample labeling
The cDNA was labeled during first strand synthesis by
using a fluorescence-tagged (Cy5) random octameric
primer. Briefly, 10 μg total RNA and 1 μg random primer
were mixed and incubated at 70°C for 10 min, then 5 ×
first-strand buffer, 0.1 M DTT, 5 mM unlabeled dNTP mix,
Cy5-dCTP, RNA inhibitor, and Superscript II (200 U/μl)
were added and incubated at 42°C for 2 h, then denatured at
70°C for 10 min. NaOH was added to hydrolyze RNA to
stop the reaction of reverse transcription, and then HEPES
was added to neutralize it. The labeled cDNA was purified
by using the QIAquick Nucleotide Removal Kit (Qiagene).
Microarray hybridization
The labeled cDNAs and Cy3-tagged oligonucleotides
complementary to the control probes were dissolved in 6 ×
SSPE/5 × Denhardt hybridization buffer and were
hybridized with the miRNA oligonucleotide microarray
for 16 h at 42°C. Then the slides were washed with
buffer I (2 × SSC/0.5% SDS) for 15 min at 42°C, buffer
II (1 × SSC/0.1% SDS) for 10 min at 42°C, buffer III
(0.1 × SSC) for 5 min at room temperature, dipped in
double-distilled water for 1 min at room temperature, and
then dried. The slides were scanned by an Agilent
scanner (G2565AA) at 535 and 635 nm.
Statistical analysis
The images were split into two, Cy3 and Cy5 channels, and
each channel was imported into the Imagene Software 7.0
to read the signal value. The Cy3 signal was used as
reference for the spot size of each miRNA oligo on the
slides. The expression level of each miRNA in the sample
labeled by Cy5 was normalized by a median method
according to the Cy3 signal between two microarrays. So,
1420 Childs Nerv Syst (2006) 22:1419–1425the Cy5 signal, after normalization, gave the expression
level of each miRNA. Clustering was carried out by
Genespring Software 8.0 according to Cy5 intensity.
Northern blot analysis
Forty micrograms of total RNA from each sample was
separated on 15% acrylamide denaturing gels (8 M urea)
and then transferred to Hybond N+ membranes
(Amersham) by electrophoresis for Northern blots. The
filters were crosslinked with 150 mJ of UV (Bio-Rad) and
baked at 80°C for 1 h. The specific oligo probes
complementary to the corresponding miRNAs were la-
beled at the 5′ end by using T4 polynucleotide kinase with
32P-γ-ATP (Amersham). The sequence list of probes for
Northern blots were: miR-92-2: 5′- CAGGCCGGGA
CAAGTGCAATA-3′;m i R - 9 :5 ′- TCATACAGCTAGA
TAACCAAAGA-3′; miR-9*: 5′-ACTTTCGGTTATC
TAGCTTTA-3′;m i R - 1 5 a :5 ′- CACAAACCATTA
TGTGCTGCTA-3′;m i R - 1 7 :5 ′- ACAAGTGCCTTCA
CTGCAGT-3′; miR-20: 5′-CTACCTGCACTATAAG
CACTTTA-3′; miR-106a: 5′- GCTACCTGCACTGTAAG
CACTTTT-3′,a n dU 6 :5 ′-CGTTCCAATTTTAGTA
TATGTGCTGCCGAAGCGA-3′ [10]. U6 on the mem-
brane served as loading control. Prehybridization and
hybridization were carried out using ExpressHyb Hybrid-
ization Solution (Clontech) according to the manufacturer’s
instructions. Membranes were washed at room temperature,
twice with 2 × SSC, 0.1% SDS and twice with 0.5 × SSC,
0.1% SDS. The blots were exposed on Molecular Dynam-
ics Phosphorimager screens and signals were quantified
using ImageQuant (Molecular Dynamics). For reuse, blots
were stripped by boiling in 0.5% SDS for 20 min and
scanned on Phosphorimager screens. Blots without radio-
active signals were re-hybridized and re-used up to six
times without influencing the quality of radioactive signals.
Results
MiRNA oligo nucleotide microarray construction
We designed 243 oligonucleotide probes and covered 158
human miRNAs from http://microrna.sanger.ac.uk/cgi-bin/
sequences/browse.pl and from publications. Nine tRNAs
served as positive controls. The oligonucleotide probes
were 40 nt in length. For 67 miRNAs, two different probes
were designed, one containing the active site and the other
specific for the precursor. Using this strategy, we were able
to analyze the miRNA and pre-miRNA in the same
experiment. A control oligo probe, which was not homol-
ogous to any human gene sequence, was designed for
spotting and quality control. All miRNA probes were
dissolved in phosphate buffer at 25 μmol/ml and the
control probe was mixed with each miRNA probe at
2 μmol/ml. The microarray slides were printed on an
Ominigride 100 machine (Gene Machine). Each oligo
probe was spotted in triplicate.
To develop the optimal conditions for the OMA, we
compared mRNA and total RNA as the starting sample.
Two micrograms of mRNA and 10 μg of total RNA were
separately labeled during the reverse transcription reaction
and hybridized to the OMA. The results indicated that
mRNA had a relatively low signal compared to the total
RNA, suggesting that mRNA had little influence on the
results (Fig. 1d), so total RNA could be used for the
Fig. 1 miRNA oligonucleotiede
microarrary construction. a The
signal at hybridization times of
6 and 16 h was much higher
than that at 4 h. b A hybridiza-
tion temperature of 42°C was
optimal for the microarray. c On
testing quantities of total RNA
from 5 to 20 μg, the signal
was highest at 10 μg. d Com-
parison of total RNA and
mRNA as the starting sample.
The 100 highest signal pairs
were chosen, and signal values
greater than 3,000 were
shown as 3,000. The results
indicated that mRNA had little
influence on the signal, so total
RNA could be used as the
starting material
Childs Nerv Syst (2006) 22:1419–1425 1421microarray experiment. The microarray hybridization time
was tested at 4, 6, and 16 h. The hybridization signals at 6 h
were considerably higher than those at 4 h, while the
signals at 16 h were only slightly higher than those at 6 h
(Fig. 1a). To test the OMA sensitivity, quantities of total
RNA ranging from 5 to 20 μg were labeled and then
hybridized to the OMA (Fig. 1c). The strongest signal was
obtained at 10 μg total RNA. To find the optimal
temperature, we tested hybridization at 42, 50, and 55°C.
The signal was very low at 50 and 55°C (Fig. 1b). From the
above results, we chose 10 μg total RNA and 42°C
hybridization for 16 h in all OMA experiments.
Distinct miRNA profiling in different organs during human
development
Total RNAs of samples from human fetal organs at G12w
and G24w were labeled during reverse transcription. The
labeled cDNAs hybridized to the OMA. After data
processing, we found that 72–83% of the miRNAs were
expressed in human fetal organs, in which the most
miRNAs were expressed in G24w cerebrum. Distinct
miRNA expression patterns were found in different organs
at each developmental stage (Fig. 2a). Some miRNAs were
seen in all samples from both embryonic stages (e.g., let-7d,
miR-193, miR-7-3, miR-185, and miR-328, among others);
they represent a type of restricted spatial and temporal
expression pattern. These miRNAs were uniformly
expressed over time, which suggests more general roles in
gene regulation.
To test the replicability of the microarray, the G24w
heart sample was labeled and hybridized in triplicate. The
results from different detection batches were highly
reproducible (Fig. 2b). Similar miRNA expression patterns
were seen in samples from developmentally proximal
organs, indicating that a miRNA expression profile can be
Fig. 2 Profiles of miRNome
expression in human G12w and
G24w fetal organs. a Distinct
patterns of miRNA expression
in different human fetal organs
(abbreviation listed below). All
of the data represent the average
of at least three replicates from
the same organ. b The same
G24w heart sample triplicate
chip results showed good reli-
ability. Each result was from
three replicates of the array. c
Three stage-specific miRNAs,
miR-92-2, miR-25, and miR-
321, were expressed in G24w
and G12w liver and lung. The
bar represents the microarray
signal intensity from 1,000 to
10,000. The blue line on the left
indicates that the four miRNAs
were clustered by cluster soft-
ware analysis. C cerebrum, Hr
heart, K kidney, Li liver, Lu
lung, O ovary, P pancreas, S
spleen, Vc cervical spinal cord,
Vl lumbar spinal cord, Vs sacral
spinal cord, Vt thoracic spinal
cord
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from the same endodermal layer. Three different miRNAs,
miR-92-2, miR-25, and mirR-321, were predominantly
expressed in liver and lung at G24w compared with the
same organs at G12w (Fig. 2c). As an indicator of miRNA
expression level, the color of samples from G24w organs
was brighter than those from G12w organs. So, the
miRNA expression profile can be used as a biomarker of
developmental stage.
CNS specifically and higher expressed microRNAs
In our study, we found four CNS specifically expressed
microRNAs, miR-9, miR-9*, miR-124a, and miR-125b,
in which miR-124a and miR-125b are expressed higher
in G24w cerebrum than in G12w. At the same time,
miR-15a, miR-106a, and miR-17–92 cluster members
w e r ef o u n de x p r e s s e dr e l a t i v e l yh i g h e ri nC N St i s s u e s
than other tissues. To validate the reliability of the
microarray data, we selected seven CNS specifically and
higher expressed miRNAs and designed specific probes
for Northern blot analysis. The miRNAs were: miR-9,
miR-9*, miR-15a, miR-106a, and miR-17–92 cluster
members including miR-17, miR-20 and miR-92-1,
which are located in the genomic site of both terminals
and in the middle of the cluster. We found good
consistency between the Northern blot and microarray
data, as shown by the results from the selected miR-15a
and miR-106a (Fig. 3).
MiR-9, miR-9*, miR-124a, and miR-125b known to be
specifically expressed in rat nervous system, are also only
expressed in the human fetal nervous system found by
microarray and Northern blot at the same time (Fig. 4).
Analysis of the array results indicated that miR-9 and
miR-9* probably originated from the expressed pre-
mi-RNA of chromosome 5 and may play key roles in
human nervous system development. So it can be
concluded that miRNA microarrays can identify different
pre-miRNA origins by using different oligo probes.
Members of the miR-17–92 cluster, which contains six
pre-miRNAs within about 1 kb on human chromosome 13,
share the same expression profile [11]. The microarray and
Northern blot results showed that these six miRNAs had the
same expression pattern (Fig. 5), suggesting that clustered
miRNAs have the same transcript and share the same
promoter element.
Discussion
The small size of miRNAs requires more sensitive tools for
quantitative analysis. Although the optimized method of
RT-Q-PCR can indirectly detect mature miRNAs [12], the
efficiency of detection is relatively low. Currently, the most
reliable method for the study of miRNA expression is
Northern blot analysis with polyacrylamide gels. This
method can distinguish pre-miRNA and miRNA at the
same time, although the technique is relatively insensitive
owing to the large total RNA volume needed, and it is
labor-intensive.
The miRNA oligonucleotide microarray provides a
novel method to carry out genome-wide microRNA
profiling in human samples. We used total RNA as the
sample for the microarray test, not just labeling filtered low
molecular weight RNA, which could change the ratio of
pre-miRNA to miRNA. So the profile we generated was
that of pre-miRNAs and miRNAs. Owing to its high
throughput and small sample requirement, the miRNA
OMA can be used as screening method in miRNA research.
Some microRNAs are within the introns of host genes.
Intronic miRNAs are usually expressed in coordination
with their host gene mRNA, suggesting that they are
generally derived from a common transcript [13]. Some
human microRNAs are even processed from capped,
polyadenylated transcripts and can function as mRNAs
[14]. Therefore, recognition of these miRNA gene families
Fig. 3 Expression of miR-15a and miR-106a, detected by Northern
blot. were in accord with the signals detected by microarray. The
abbreviations are as in the legend of Fig. 2. The miR-15a and miR-
106a are shown on the left, indicating the corresponding expression
detected by Northern blot. The microarray results are presented
numerically, indicated by Oligo. U6 snRNA detected by Northern blot
was used as detection control
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and in understanding the pathways of miRNA biogenesis.
Through GeneCluster software analysis, we found that
miR-17, miR-18, miR-19a, miR-19b, miR-20, and miR-92-
1 form a cluster.
Based on the bioinformatics study and previous work, we
attemptedtoverifythehypothesisthatthemiR-17–92cluster
may share the same expression unit. We searched for the
genome location and possible co-expressed mRNA and
found the six pre-miRNAs within about 1 kb on human
chromosome 13; the possible co-expressed mRNA is human
chromosome 13 open reading frame 25 (C13 orf25),
transcript variant 2 mRNA, indicating that the miR-17–92
cluster members are intronic miRNAs. Analysis of clustered
Fig. 5 Co-expressed miR-17-92 cluster miRNAs. a The three known
human miRNA clusters. The miR-17–92 cluster contains six pre-
miRNAs within about 1 kb on chromosome 13. b The miR-17, miR-
20, and miR-92-1 expression profiles detected by Northern blot (the
name of the miRNA and pre-miRNA are given on the left and the
abbreviations are as in the legend of Fig. 2.) and microarray (results
given numerically and marked as miR-17-oligo, miR-20-oligo, and
miR-92-1-oligo). U6 snRNA detected by Northern blot was used as
detection control
Fig. 4 miR-9 and miR-9* were expressed specifically in the human
nervous system. a miR-9 and miR-9* can be expressed from human
chromosomes 1, 5, and 15 and form three types of pre-miRNA. The
secondary structures of pre-miRNAs from the Sanger miRNA register
website were predicted with mfold software. The pre-miRNAs can be
excised by Dicer into the same mature miRNAs—miR-9 and miR-9*.
b Northern blot results probed with miR-9 and miR-9*. The
abbreviations are as in the legend of Fig. 2. The microarray results
are presented numerically, indicated by Oligo. U6 snRNA detected by
Northern blot was used as detection control
1424 Childs Nerv Syst (2006) 22:1419–1425miRNA expression profiles suggested that the six clustered
miRNAs may have the same promoter element.
In our study, we found that four miRNAs were only
expressed in the human fetal nervous system, indicating
that they may play important roles in human nervous
system development. Before our study, Krichevsky et al.
found miR-9 and miR-9* specifically expressed in mouse
brain, and they were de-regulated in presenilin-1 null mice,
which exhibited severe developmental defects of the brain
[5]. MiR-9 and miR-9* may modulate critical development
processes in human brain development and changes in
stage and level of expression may induce major develop-
mental errors. Giraldez et al. showed that miR-430
regulates brain morphogenesis in zebrafish and MZdicer
mutants undergo axis formation and differentiate multiple
cell types but display abnormal morphogenesis during
gastrulation, brain formation, somitogenesis, and heart
development. Injection of miR-430 rescues the brain
defects in MZdicer mutants, revealing essential roles for
miRNAs during morphogenesis [15].
No human miR-430 is registered online at present, but
miR-17, miR-20, and miR-106a have the same sequence at
nucleotides 2–8. Giraldez thought this is most important for
recognition. In our study, members of the miR-17–92 cluster
were highly expressed in the nervous system, but no human
miRNA expression homologous to miR-430 was detected by
Northern blot with a pre-miR-430 probe (data not shown). In
humans, it is not miR-430 that plays a critical role in nervous
system morphogenesis. So these results indicated that there
are differences in the mechanisms of brain morphogenesis
between human and zebra fish.
This raises the question of whether the specifically
expressed miR-9, miR-9*, and higher expressed miR-17–
92 cluster are functionally linked, or perhaps this just
reflects higher nonspecific Dicer activity. He et al.
compared B-cell lymphoma samples and cell lines to
normal tissues and found that the levels of the primary or
mature miRNAs derived from the miR-17–92 locus are
often substantially increased in these cancers, implicating
the miR-17–92 cluster as a potential human oncogene [16].
O’Donnell et al. found that c-Myc-regulated miR-17 and
miR-20 modulate E2F1 expression [17]. These findings
indicate that the miR-17–92 cluster may be a common
channel to regulate cell differentiation.
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